About Medicis Pharmaceutical (NYSE:MRX)
Medicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta).
Industry, Sector and Symbol
Industry Generic Pharmaceuticals
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Medicis Pharmaceutical (NYSE:MRX) Frequently Asked Questions
What is Medicis Pharmaceutical's stock symbol?
Medicis Pharmaceutical trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRX."
Who are some of Medicis Pharmaceutical's key competitors?
Who are Medicis Pharmaceutical's key executives?
Medicis Pharmaceutical's management team includes the folowing people:
- Robert Roswell Chai-Onn, Executive Vice President, General Counsel, Secretary, Director (Age 44)
- Howard Bradley Schiller, Officer, Director (Age 53)
- Ryan Weldon, Officer, Director
How do I buy Medicis Pharmaceutical stock?
Shares of Medicis Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Medicis Pharmaceutical?
Medicis Pharmaceutical's mailing address is 8125 N Hayden Rd, SCOTTSDALE, AZ 85258-2463, United States. The healthcare company can be reached via phone at +1-212-5992000.
MarketBeat Community Rating for Medicis Pharmaceutical (MRX)MarketBeat's community ratings are surveys of what our community members think about Medicis Pharmaceutical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Medicis Pharmaceutical (NYSE:MRX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Medicis Pharmaceutical (NYSE:MRX) Earnings History and Estimates Chart
Medicis Pharmaceutical (NYSE MRX) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Medicis Pharmaceutical (NYSE:MRX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Medicis Pharmaceutical (NYSE:MRX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Medicis Pharmaceutical (NYSE MRX)
No insider trades for this company have been tracked by MarketBeat.com
Medicis Pharmaceutical (NYSE MRX) News Headlines
Medicis Pharmaceutical (NYSE:MRX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Medicis Pharmaceutical (NYSE:MRX) Income Statement, Balance Sheet and Cash Flow Statement
Medicis Pharmaceutical (NYSE MRX) Stock Chart for Friday, December, 15, 2017